(Q35685854)

9 August 2017

1 reference

title

The role of prostate-specific antigen in the clinical evaluation of prostatic disease (English)

1 reference

9 August 2017

Denmeade SR

1

1 reference

9 August 2017

Isaacs JT

series ordinal

2

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

93 Suppl 1

1 reference

9 August 2017

page(s)

10-15

1 reference

An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Free prostate-specific antigen in serum is becoming more complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Age-specific reference ranges for serum prostate-specific antigen in black men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Immunohistochemical finding of alpha-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04634.X

10.1111/J.1464-410X.2003.04634.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference